Clinical Outcomes in Patients with FLT3-ITD-Mutated Relapsed/Refractory Acute Myelogenous Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Quizartinib or Salvage Chemotherapy in the QuANTUM-R Trial

Siddhartha Ganguly, Jorge E Cortes, Alwin Krämer, Mark J Levis, Giovanni Martinelli, Alexander E Perl, Nigel H Russell, Meena Arunachalam, Cedric Dos Santos, Guy Gammon, Arnaud Lesegretain, Derek E Mires, Hoang Pham, Yibin Wang, Samer K Khaled

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Clinical Outcomes in Patients with FLT3-ITD-Mutated Relapsed/Refractory Acute Myelogenous Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Quizartinib or Salvage Chemotherapy in the QuANTUM-R Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences